Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets

• Váldodahkkit: Luis C. Vesga (Dahkki), Camilo A. Ruiz-Hernández (Dahkki), Jeimmy J. Alvarez-Jacome (Dahkki), Jonny E. Duque (Dahkki), Bladimiro Rincon-Orozco (Dahkki), Stelia C. Mendez-Sanchez (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Although there are existing vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), new COVID-19 cases are increasing due to low immunization coverage and the emergence of new variants. For this reason, new drugs to treat and prevent severe COVID-19 are needed. Here, we provid...